Breast cancer drug affects brain function

Breast cancer drug affects brain function

LITROSOLE (daily mail)

London: Middle East Online

LONDON (Reuters) – A drug administered by the British National Health Service to breast cancer patients could affect brain function and memory, according to a study.
Leterosol is primarily used to treat breast cancer and was prescribed more than 755,866 times last year for treatment in Britain, according to National Health Service (NHS) numerical statistics.
Although cancer research conducted in the UK suggests that up to 30% of patients experience side effects such as fever and fatigue, new research suggests that complications could be more serious, reported the Daily Mail .
The study, led by the University of Toronto and led by Dr. Nicole Gervais, focused on experimenting with this drug in monkeys after only four weeks, indicating that the drug was reducing brain cell function in an area called Ammonium, located in the central temporal lobe of the brain. Integrate information from short-term memory into long-term memory.
Lactoseol is only used in women with breast cancer and menopause. Indeed, they no longer produce estrogen through the ovaries, so the hormone comes only from the aromatase.
The drug is associated with joint pain and elevated cholesterol levels in one in ten people, as well as a loss of appetite, hair loss and vaginal dryness in one percent of cases. It is often given after surgery or chemotherapy to prevent the recurrence or spread of cancer.
Lactoseol can also cause depression, forgetfulness and insomnia.

United Kingdom

The health